JPH07252248A - Beta-lactam-based compound and its sterically selective production - Google Patents
Beta-lactam-based compound and its sterically selective productionInfo
- Publication number
- JPH07252248A JPH07252248A JP6785194A JP6785194A JPH07252248A JP H07252248 A JPH07252248 A JP H07252248A JP 6785194 A JP6785194 A JP 6785194A JP 6785194 A JP6785194 A JP 6785194A JP H07252248 A JPH07252248 A JP H07252248A
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- general formula
- solution
- represented
- lactam
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title claims description 9
- 150000003952 β-lactams Chemical class 0.000 title claims description 9
- 238000004519 manufacturing process Methods 0.000 title claims description 6
- 229910052751 metal Inorganic materials 0.000 claims abstract description 10
- 239000002184 metal Substances 0.000 claims abstract description 10
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 9
- 150000002466 imines Chemical class 0.000 claims abstract description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 8
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 5
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 4
- 150000002367 halogens Chemical class 0.000 claims abstract description 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 3
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 9
- 150000001576 beta-amino acids Chemical class 0.000 claims description 6
- 230000000707 stereoselective effect Effects 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 4
- 150000002431 hydrogen Chemical group 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 150000002168 ethanoic acid esters Chemical class 0.000 claims description 3
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims description 2
- 238000007363 ring formation reaction Methods 0.000 claims description 2
- 150000003862 amino acid derivatives Chemical class 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract description 16
- 235000019439 ethyl acetate Nutrition 0.000 abstract description 5
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 abstract description 3
- 230000003115 biocidal effect Effects 0.000 abstract 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 30
- 239000000243 solution Substances 0.000 description 27
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 15
- 239000000126 substance Substances 0.000 description 15
- 239000000203 mixture Substances 0.000 description 14
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 6
- 239000012300 argon atmosphere Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 235000002597 Solanum melongena Nutrition 0.000 description 4
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 4
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- -1 lactam compounds Chemical class 0.000 description 3
- 229910052744 lithium Inorganic materials 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- WMOVHXAZOJBABW-UHFFFAOYSA-N tert-butyl acetate Chemical compound CC(=O)OC(C)(C)C WMOVHXAZOJBABW-UHFFFAOYSA-N 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- IFMWVBVPVXRZHE-UHFFFAOYSA-M chlorotitanium(3+);propan-2-olate Chemical compound [Cl-].[Ti+4].CC(C)[O-].CC(C)[O-].CC(C)[O-] IFMWVBVPVXRZHE-UHFFFAOYSA-M 0.000 description 2
- 229940043279 diisopropylamine Drugs 0.000 description 2
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- ABFPKTQEQNICFT-UHFFFAOYSA-M 2-chloro-1-methylpyridin-1-ium;iodide Chemical compound [I-].C[N+]1=CC=CC=C1Cl ABFPKTQEQNICFT-UHFFFAOYSA-M 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- WKDDRNSBRWANNC-ATRFCDNQSA-N Thienamycin Chemical compound C1C(SCCN)=C(C(O)=O)N2C(=O)[C@H]([C@H](O)C)[C@H]21 WKDDRNSBRWANNC-ATRFCDNQSA-N 0.000 description 1
- WKDDRNSBRWANNC-UHFFFAOYSA-N Thienamycin Natural products C1C(SCCN)=C(C(O)=O)N2C(=O)C(C(O)C)C21 WKDDRNSBRWANNC-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- HAXFWIACAGNFHA-UHFFFAOYSA-N aldrithiol Chemical compound C=1C=CC=NC=1SSC1=CC=CC=N1 HAXFWIACAGNFHA-UHFFFAOYSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- MNFORVFSTILPAW-UHFFFAOYSA-N azetidin-2-one Chemical compound O=C1CCN1 MNFORVFSTILPAW-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- HHXMXAQDOUCLDN-RXMQYKEDSA-N penem Chemical compound S1C=CN2C(=O)C[C@H]21 HHXMXAQDOUCLDN-RXMQYKEDSA-N 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- IUBQJLUDMLPAGT-UHFFFAOYSA-N potassium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([K])[Si](C)(C)C IUBQJLUDMLPAGT-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- JLTRXTDYQLMHGR-UHFFFAOYSA-N trimethylaluminium Chemical compound C[Al](C)C JLTRXTDYQLMHGR-UHFFFAOYSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明はカルバペネム系抗生物質
の重要合成中間体へ誘導できる新規なβ−ラクタム誘導
体及びその光学異性体の立体選択的な製法に関するもの
である。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a novel β-lactam derivative which can be converted into an important synthetic intermediate of carbapenem antibiotics and a stereoselective process for producing an optical isomer thereof.
【0002】[0002]
【従来の技術】チエナマイシンなど抗菌活性を有するβ
−ラクタム系化合物及びその製造法は多数研究されてい
るが、その有用性から簡便で且つ立体選択性の高い合成
反応が望まれている。BACKGROUND ART β having antibacterial activity such as thienamycin
-Many studies have been conducted on lactam compounds and methods for producing the same, but simple and highly stereoselective synthetic reactions have been desired due to their usefulness.
【0003】[0003]
【発明が解決しようとする課題】本発明の目的は新規な
β−ラクタム誘導体とその立体選択的製造方法を提供す
ることである。SUMMARY OF THE INVENTION An object of the present invention is to provide a novel β-lactam derivative and a stereoselective production method thereof.
【0004】[0004]
【課題を解決するための手段】本発明は一般式〔I〕The present invention has the general formula [I]
【化6】 〔Qは(C1 〜C6 のアルキル、C1 〜C6 のアルコキ
シで置換されてもよい)フェニル又は(C1 〜C6 のア
ルキル、C1 〜C6 のアルコキシで置換されてもよい)
アラルキルを表し、Rは水素、C1 〜C6 のアルキルを
表し、Zは水素、C1 〜C6 のアルキル、(C1 〜C6
のアルキル、C1 〜C6 のアルコキシ、ハロゲンで置換
されていてもよい)フェニル、C1 〜C6 アルコキシ又
はC1 〜C6 アルキルチオを表す。〕で表されるβ−ア
ミノ酸誘導体および一般式〔II〕[Chemical 6] [Q is phenyl (which may be substituted with C1 to C6 alkyl, C1 to C6 alkoxy) phenyl or (C1 to C6 alkyl, which may be substituted with C1 to C6 alkoxy)
Represents aralkyl, R represents hydrogen, C1 to C6 alkyl, Z represents hydrogen, C1 to C6 alkyl, (C1 to C6)
Alkyl, C1 -C6 alkoxy, optionally substituted by halogen) phenyl, C1 -C6 alkoxy or C1 -C6 alkylthio. ] The β-amino acid derivative represented by the general formula [II]
【化7】 〔Q、Zは前記と同じ意味を表す。〕で表されるβ−ラ
クタム誘導体であり、一般式〔III〕[Chemical 7] [Q and Z represent the same meaning as described above. ] A β-lactam derivative represented by the general formula [III]
【化8】 (Q、Zは前記と同じ意味を表す。)で表される光学活
性イミンと一般式〔IV〕[Chemical 8] (Q and Z have the same meanings as described above.) And an optically active imine represented by the general formula [IV]
【化9】 (Metは金属を表し、Rは前記と同じ意味を表す。)
で表される酢酸エステルの金属エノラートを反応させ、
環化することを特徴とする立体選択的β−ラクタムの製
造方法である。[Chemical 9] (Met represents a metal and R represents the same meaning as described above.)
By reacting a metal enolate of an acetic acid ester represented by
A method for producing a stereoselective β-lactam, which comprises cyclizing.
【0005】ここで酢酸エステルの金属エノラート中の
金属とはエノラートを形成するものなら何でもよく、具
体的には、Li、ZnX 、AlR'3 ・Li、Ti(OR')3、SnR'3 ・
Li等〔X はBr、Cl、F 、I のハロゲンを表し、R'はメチ
ル、エチル、プロピル、イソプロピル、ブチル、sec-ブ
チル、t-ブチルなどのC1 〜C6 のアルキルを表す。〕
である。[0005] well where the metal in the metal enolate of acetic acid ester anything that forms the enolate, specifically, Li, ZnX, AlR '3 · Li, Ti (OR') 3, SnR '3 ·
Li, etc. [X represents halogen such as Br, Cl, F and I, and R'represents C1 to C6 alkyl such as methyl, ethyl, propyl, isopropyl, butyl, sec-butyl and t-butyl. ]
Is.
【0006】一般式〔I〕には、次の光学異性体が存在
するが、エノラートの金属種やエステル部位、反応溶媒
などの反応条件を選択することにより立体選択的にそれ
らを製造するこができる。The following optical isomers exist in the general formula [I], and they can be stereoselectively produced by selecting the reaction conditions such as the metal species of the enolate, the ester moiety and the reaction solvent. it can.
【化10】 [Chemical 10]
【0007】また、一般式〔I〕を環化した一般式〔I
I〕にも次の光学異性体が存在するが、環化の条件下で
は〔I〕の立体化学は損なわれない。The general formula [I] obtained by cyclizing the general formula [I]
I] has the following optical isomers, but the stereochemistry of [I] is not impaired under the condition of cyclization.
【化11】 [Chemical 11]
【0008】次に具体的に製造方法を説明する。溶媒
中、室温以下、酢酸エステル誘導体とリチウムジイソプ
ロピルアミド(LDA)によりリチウムエノラートを生
成させる。この溶液をイミンを含んだ溶液にゆっくりと
滴下する。その後徐々に室温に昇温し、数〜数10時間
攪拌する。反応終了後、抽出、精製して目的化合物を得
る。Next, the manufacturing method will be specifically described. Lithium enolate is formed by acetic ester derivative and lithium diisopropylamide (LDA) in a solvent at room temperature or lower. This solution is slowly added dropwise to the solution containing the imine. After that, the temperature is gradually raised to room temperature and stirred for several to several tens of hours. After completion of the reaction, extraction and purification are carried out to obtain the target compound.
【0009】ここで溶媒は、テトラヒドロフラン(TH
F)、ジエチルエーテル、ジメトキシエタン(DM
E)、ジメチルホルムアミド(DMF)、塩化メチレ
ン、トルエン、ヘキサメチルホスフォリックトリアミド
(HMPA)など及びそれらの混合溶媒を用いることが
できる。反応温度は室温以下、好ましくは−150℃〜
0℃である。またリチウムエノラートにクロロチタント
リイソプロポキシド又は塩化亜鉛などを加えて金属交換
を行うことによりチタンエノラート又は亜鉛エノラート
を生成することができる。Here, the solvent is tetrahydrofuran (TH
F), diethyl ether, dimethoxyethane (DM
E), dimethylformamide (DMF), methylene chloride, toluene, hexamethylphosphoric triamide (HMPA), and the like, and mixed solvents thereof can be used. The reaction temperature is room temperature or lower, preferably from -150 ° C.
It is 0 ° C. Further, titanium enolate or zinc enolate can be produced by adding chlorotitanium triisopropoxide, zinc chloride or the like to lithium enolate and performing metal exchange.
【0010】原料となる光学活性イミンは次式によって
合成できる。The optically active imine as a raw material can be synthesized by the following formula.
【化12】 [Chemical 12]
【0011】また、得られた本発明化合物は例えば次式
によりカルバペネム、ペネム系抗菌性物質中間体として
有用な2−アゼチジノンに変換することが可能である。The obtained compound of the present invention can be converted into 2-azetidinone useful as an intermediate for carbapenem and penem antibacterial substances, for example, by the following formula.
【化13】 [Chemical 13]
【0012】[0012]
【実施例】次に実施例を挙げて本発明をさらに具体的に
説明するが本発明はこれに限定されるものではない。化
合物はNMR、IR及びMSにより同定し、キャピラリ
ーGLC、HPLCにより立体異性体の比を決定した。EXAMPLES Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited thereto. The compound was identified by NMR, IR and MS, and the ratio of stereoisomers was determined by capillary GLC and HPLC.
【0013】実施例1 3−(p−メトキシフェニルア
ミノ)−3−(4,5−ジメトキシメチル−1,3−ジ
オキソラン−2−イル)プロピオン酸t−ブチルエステ
ルの合成Example 1 Synthesis of 3- (p-methoxyphenylamino) -3- (4,5-dimethoxymethyl-1,3-dioxolan-2-yl) propionic acid t-butyl ester
【化14】 アルゴン雰囲気下30ml 2口ナスフラスコにジイソ
プロピルアミン 308mg(3.1mmol)のTH
F 3ml溶液を入れ、−78℃に冷却した。1.56
Nのn−ブチルリチムのヘキサン溶液2.0ml(3.
1mmol)を加え−78℃で15分間攪拌した。その
溶液に酢酸t−ブチル 360mg(3.1mmol)
のTHF 3ml溶液をゆっくり滴下し−78℃で15
分間攪拌した。1.0Nの塩化トリイソプロポキシチタ
ンのヘキサン溶液3.1ml(3.1mmol)をゆっ
くり加え−78℃で15分間攪拌した。その溶液を−1
10℃に冷却しイミン〔III’〕 150mg(0.
51mmol)のTHF3ml溶液をゆっくりと滴下し
−95℃まで自然昇温させながら3時間攪拌した。リン
酸緩衝溶液を加え反応を停止させ、セライト濾過し、酢
酸エチルで抽出後、無水硫酸ナトリウムで乾燥した。濃
縮後シリカゲル薄層クロマトグラフィー(ヘキサン:エ
ーテル=1:3)により精製し表記のβ−アミノエステ
ルを得た。 収量 63mg(収率30%) Rf 0.4(ヘキサン:エーテル=1:3) (S:R)=20:80 (HPLC ヘキサン:酢
酸エチル=5:1) Rt 63.52 min 68.11 min 1H-NMR(CDCl3) δ 1.40(S,9H),2.36-2.59(m,2H),3.37-
3.57(m,11H),3.73(s,3H),3.96-4.04(m,3H),5.21(d,J=1.
98,1H),6.64(d,J=9.07,2H),6.75(d,J=9.07,2H) IR(neat) cm-1 3360,2900,1730,1510,1240,1150[Chemical 14] Diisopropylamine 308 mg (3.1 mmol) TH in a 30 ml two-necked eggplant flask under argon atmosphere.
F 3 ml solution was added and cooled to -78 ° C. 1.56
2.0 ml of a hexane solution of n-butyllithium of N (3.
1 mmol) was added and the mixture was stirred at -78 ° C for 15 minutes. 360 mg (3.1 mmol) of t-butyl acetate was added to the solution.
THF solution (3 ml) was slowly added dropwise at -78 ° C for 15 minutes.
Stir for minutes. 3.1 ml (3.1 mmol) of a hexane solution of 1.0 N triisopropoxytitanium chloride was slowly added, and the mixture was stirred at -78 ° C for 15 minutes. The solution -1
After cooling to 10 ° C., imine [III ′] 150 mg (0.
A solution of 51 mmol) in THF (3 ml) was slowly added dropwise, and the mixture was stirred for 3 hours while allowing the temperature to naturally rise to -95 ° C. The reaction was stopped by adding a phosphate buffer solution, the mixture was filtered through Celite, extracted with ethyl acetate, and dried over anhydrous sodium sulfate. After concentration, the residue was purified by silica gel thin layer chromatography (hexane: ether = 1: 3) to obtain the indicated β-amino ester. Yield 63 mg (yield 30%) Rf 0.4 (hexane: ether = 1: 3) (S: R) = 20: 80 (HPLC hexane: ethyl acetate = 5: 1) Rt 63.52 min 68.11 min 1H-NMR (CDCl 3 ) δ 1.40 (S, 9H), 2.36-2.59 (m, 2H), 3.37-
3.57 (m, 11H), 3.73 (s, 3H), 3.96-4.04 (m, 3H), 5.21 (d, J = 1.
98,1H), 6.64 (d, J = 9.07,2H), 6.75 (d, J = 9.07,2H) IR (neat) cm -1 3360,2900,1730,1510,1240,1150
【0014】実施例2 3−(p−メトキシフェニルア
ミノ)−3−(4,5−ジメトキシメチル−1,3−ジ
オキソラン−2−イル)プロピオン酸t−ブチルエステ
ルの合成Example 2 Synthesis of 3- (p-methoxyphenylamino) -3- (4,5-dimethoxymethyl-1,3-dioxolan-2-yl) propionic acid t-butyl ester
【化15】 アルゴン雰囲気下30ml 2口ナスフラスコにTHF
3mlとカリウムヘキサメチルジシラジドの0.5M
トルエン溶液1.08ml(0.54mmol)を入れ
−78℃に冷却し攪拌した。酢酸t−ブチル 62.7
mg(0.54mmol)のTHF 3ml溶液をゆっ
くりと加え−78℃で15分間攪拌した。その溶液に塩
化亜鉛73.6mg(0.54mmol)を加え、0℃
まで昇温し1時間攪拌した。再び反応溶液を−80℃に
冷却しイミン〔III’〕 40mg(0.14mmo
l)のTHF 3ml溶液をゆっくり加え室温まで自然
昇温させながら48時間攪拌した。以下実施例1と同様
の処理を行った。 収量 20.1mg(収率36%) (S:R)= 8:92[Chemical 15] THF in a 30 ml 2-neck eggplant flask under argon atmosphere
0.5 ml of 3 ml and potassium hexamethyldisilazide
1.08 ml (0.54 mmol) of a toluene solution was added and the mixture was cooled to -78 ° C and stirred. T-Butyl acetate 62.7
A solution of mg (0.54 mmol) in 3 ml of THF was slowly added, and the mixture was stirred at -78 ° C for 15 minutes. 73.6 mg (0.54 mmol) of zinc chloride was added to the solution, and the temperature was 0 ° C.
The temperature was raised to and stirred for 1 hour. The reaction solution was cooled to −80 ° C. again, and imine [III ′] 40 mg (0.14 mmo
A solution of 1) in THF (3 ml) was slowly added, and the mixture was stirred for 48 hours while allowing the temperature to rise naturally to room temperature. Then, the same treatment as in Example 1 was performed. Yield 20.1 mg (yield 36%) (S: R) = 8: 92
【0015】実施例3 3−(p−メトキシフェニルア
ミノ)−3−(4,5−ジメトキシメチル−1,3−ジ
オキソラン−2−イル)プロピオン酸t−ブチルエステ
ルの合成Example 3 Synthesis of 3- (p-methoxyphenylamino) -3- (4,5-dimethoxymethyl-1,3-dioxolan-2-yl) propionic acid t-butyl ester
【化16】 アルゴン雰囲気下30ml 2口ナスフラスコにジイソ
プロピルアミン 41mg(0.41mmol)のTH
F 3ml溶液を入れ−78℃に冷却して攪拌した。
1.48Nのn−ブチルリチウムのヘキサン溶液0.2
7ml(0.41mmol)を加え−78℃で15分間
攪拌した。その溶液に酢酸t−ブチル 48mg(0.
41mmol)のTHF 3ml溶液をゆっくり加え−
78℃で15分間攪拌した。トリメチルアルミニウムの
1.4Nトルエン溶液0.29ml(0.41mmo
l)を加え30分間攪拌した。反応溶液を−110℃に
冷却し、イミン〔III’〕 40mg(0.14mm
ol)のTHF 3ml溶液をゆっくり滴下し−95℃
まで自然昇温させながら3時間攪拌した。以下実施例1
と同様の処理を行った。 収量 14mg(収率24%) (S:R)=89:11[Chemical 16] Diisopropylamine 41 mg (0.41 mmol) TH was added to a 30 ml 2-necked eggplant flask under an argon atmosphere.
A 3 ml F solution was added and the mixture was cooled to -78 ° C and stirred.
1.48 N n-butyllithium hexane solution 0.2
7 ml (0.41 mmol) was added and it stirred at -78 degreeC for 15 minutes. To the solution, 48 mg of t-butyl acetate (0.
41 mmol) in 3 ml of THF was slowly added-
The mixture was stirred at 78 ° C for 15 minutes. 0.29 ml of 1.4N toluene solution of trimethylaluminum (0.41 mmo
1) was added and stirred for 30 minutes. The reaction solution was cooled to −110 ° C., and imine [III ′] 40 mg (0.14 mm
solution) in THF (3 ml) was slowly added dropwise at -95 ° C.
The mixture was stirred for 3 hours while allowing the temperature to rise naturally. Example 1 below
The same process was performed. Yield 14 mg (24% yield) (S: R) = 89: 11
【0016】実施例1〜3の化合物を含め第1表に製造
例を示した。Production examples are shown in Table 1 including the compounds of Examples 1 to 3.
【0017】[0017]
【表1】 [Table 1]
【0018】実施例8 3−(p−メトキシフェニルア
ミノ)−3−(4,5−ジメトキシメチル−1,3−ジ
オキソラン−2−イル)プロピオン酸の合成Example 8 Synthesis of 3- (p-methoxyphenylamino) -3- (4,5-dimethoxymethyl-1,3-dioxolan-2-yl) propionic acid
【化17】 アルゴン雰囲気下50mlナスフラスコにβ−アミノエ
ステル〔I’−S〕39mg(0.095mmol)の
塩化メチレン 9ml溶液を入れ、0℃に冷却して攪拌
した。その溶液にトリフルオロ酢酸0.73ml(9.
5mmol)を加え室温で24時間攪拌した。反応溶液
を濃縮しシリカゲル薄層クロマトグラフィー(ヘキサ
ン:エーテル=1:3)により精製を行い表記のβ−ア
ミノ酸を得た。 収量34mg(収率100%) Rf 0.1(ヘキサン:エーテル=1:3) 1H-NMR(CDCl3) δ 2.60(broad,2H),3.35-3.61(m,11H),
3.74(s,3H),3.99(broad,3H),5.18(broad,1H),6.76(broa
d,4H) IR(neat) cm-1 3400,2900,1700,1510,1200,830[Chemical 17] Under argon atmosphere, a solution of β-amino ester [I′-S] 39 mg (0.095 mmol) in methylene chloride 9 ml was put in a 50 ml eggplant flask, cooled to 0 ° C. and stirred. 0.73 ml of trifluoroacetic acid (9.
(5 mmol) was added and the mixture was stirred at room temperature for 24 hours. The reaction solution was concentrated and purified by silica gel thin layer chromatography (hexane: ether = 1: 3) to obtain the indicated β-amino acid. Yield 34 mg (yield 100%) Rf 0.1 (hexane: ether = 1: 3) 1H-NMR (CDCl 3 ) δ 2.60 (broad, 2H), 3.35-3.61 (m, 11H),
3.74 (s, 3H), 3.99 (broad, 3H), 5.18 (broad, 1H), 6.76 (broa
d, 4H) IR (neat) cm -1 3400,2900,1700,1510,1200,830
【0019】実施例9 4−〔(4S,5S)−4,5
−ジメトキシメチル−1,3−ジオキソラン−2−イ
ル〕−1−p−メトキシフェニル−2−アゼチジノンの
合成Example 9 4-[(4S, 5S) -4,5
-Dimethoxymethyl-1,3-dioxolan-2-yl] -1-p-methoxyphenyl-2-azetidinone
【化18】 アルゴン雰囲気下30ml 2口ナスフラスコにN−メ
チル−2−クロロピリジニウムヨウ化物18mg(0.
076mmol)の塩化メチレン 1ml溶液を入れ、
0℃に冷却して攪拌した。その溶液に実施例8で得られ
たβ−アミノ酸18mg(0.051mmol)の塩化
メチレン 1ml溶液をゆっくりと滴下した。トリエチ
ルアミン 0.04ml(0.26mmol)をゆっく
り加え室温まで自然昇温させながら12時間攪拌した。
飽和食塩水を加えて反応を停止させ酢酸エチルで抽出
後、無水硫酸ナトリウムで乾燥した。濃縮後シリカゲル
薄層クロマトグラフィー(ヘキサン:エーテル=1:
3)により精製を行い、表記のβ−ラクタムを得た。 収量 0.4mg(収率4%) S:R=8:92 Rf 0.2(ヘキサン:エーテル=1:3) Rt 61.923min,65.056min(GC
SE30 50m230℃一定) 1H-NMR(CDCl3) δ 2.98-3.11(m,2H),3.32-3.51(m,10
H),3.79(s,3H),3.84-3.90(m,1H),4.04-4.09(m,1H),4.17
-4.21(m,1H),5.33(d,J=3.63,1H),6.84(d,J=8.91,2H),7.
49(d,J=8.91,1H) IR(neat) cm -1 2900,1760,1510,1380,1100[Chemical 18] N-methyl-2-chloropyridinium iodide 18 mg (0.
(076 mmol) in 1 ml of methylene chloride,
It was cooled to 0 ° C. and stirred. A solution of 18 mg (0.051 mmol) of β-amino acid obtained in Example 8 in 1 ml of methylene chloride was slowly added dropwise to the solution. Triethylamine (0.04 ml, 0.26 mmol) was slowly added, and the mixture was stirred for 12 hours while naturally warming to room temperature.
The reaction was stopped by adding saturated saline and the mixture was extracted with ethyl acetate and dried over anhydrous sodium sulfate. After concentration, silica gel thin layer chromatography (hexane: ether = 1: 1)
Purification was performed according to 3) to obtain the indicated β-lactam. Yield 0.4 mg (yield 4%) S: R = 8: 92 Rf 0.2 (hexane: ether = 1: 3) Rt 61.923 min, 65.056 min (GC
SE30 50 m 230 ° C. constant) 1H-NMR (CDCl 3 ) δ 2.98-3.11 (m, 2H), 3.32-3.51 (m, 10
H), 3.79 (s, 3H), 3.84-3.90 (m, 1H), 4.04-4.09 (m, 1H), 4.17
-4.21 (m, 1H), 5.33 (d, J = 3.63,1H), 6.84 (d, J = 8.91,2H), 7.
49 (d, J = 8.91,1H) IR (neat) cm -1 2900,1760,1510,1380,1100
【0020】実施例10 4−〔(4S,5S)−4,
5−ジメトキシメチル−1,3−ジオキソラン−2−イ
ル〕−1−p−メトキシフェニル−2−アゼチジノンの
合成Example 10 4-[(4S, 5S) -4,
Synthesis of 5-dimethoxymethyl-1,3-dioxolan-2-yl] -1-p-methoxyphenyl-2-azetidinone
【化19】 アルゴン雰囲気下50mlナスフラスコに実施例8で得
られたβ−アミノ酸7mg(0.020mmol)のア
セトニトリル 2ml溶液を入れ攪拌した。トリフェニ
ルホスフィンのアセトニトリル溶液を加え、ジピリジル
ジスルフィドのアセトニトリル溶液を加え、45℃に加
熱して13時間攪拌した。飽和食塩水により反応を停止
させ、酢酸エチルで抽出後、無水硫酸ナトリウムで乾燥
した。以下実施例9と同様の操作を行った。 収量 3.3mg(収率49%) S:R=28:72[Chemical 19] Under argon atmosphere, a solution of 7 mg (0.020 mmol) of β-amino acid obtained in Example 8 in 2 ml of acetonitrile was placed in a 50 ml eggplant-shaped flask and stirred. An acetonitrile solution of triphenylphosphine was added, an acetonitrile solution of dipyridyl disulfide was added, and the mixture was heated to 45 ° C. and stirred for 13 hours. The reaction was stopped with saturated saline, extracted with ethyl acetate, and dried over anhydrous sodium sulfate. The same operation as in Example 9 was performed below. Yield 3.3 mg (yield 49%) S: R = 28: 72
【0021】[0021]
【発明の効果】立体選択的にβ−ラクタム誘導体を得る
ことができる。The β-lactam derivative can be stereoselectively obtained.
Claims (4)
シで置換されてもよい)フェニル又は(C1 〜C6 のア
ルキル、C1 〜C6 のアルコキシで置換されてもよい)
アラルキルを表し、Rは水素、C1 〜C6 のアルキルを
表し、Zは水素、C1 〜C6 のアルキル、(C1 〜C6
のアルキル、C1 〜C6 のアルコキシ、ハロゲンで置換
されていてもよい)フェニル、C1 〜C6 アルコキシ又
はC1 〜C6 アルキルチオを表す。〕で表されるβ−ア
ミノ酸誘導体。1. A compound represented by the general formula [I]: [Q is phenyl (which may be substituted with C1 to C6 alkyl, C1 to C6 alkoxy) phenyl or (C1 to C6 alkyl, which may be substituted with C1 to C6 alkoxy)
Represents aralkyl, R represents hydrogen, C1 to C6 alkyl, Z represents hydrogen, C1 to C6 alkyl, (C1 to C6)
Alkyl, C1 -C6 alkoxy, optionally substituted by halogen) phenyl, C1 -C6 alkoxy or C1 -C6 alkylthio. ] The beta-amino acid derivative represented by these.
クタム誘導体。2. A compound represented by the general formula [II]: [Q and Z represent the same meaning as described above. ] The beta-lactam derivative represented by these.
性イミンと一般式〔IV〕 【化4】 (Metは金属を表し、Rは前記と同じ意味を表す。)
で表される酢酸エステルの金属エノラートを反応させる
ことを特徴とする請求項1記載の立体選択的β−アミノ
酸誘導体の製法3. A compound represented by the general formula [III]: (Q and Z have the same meanings as described above.) And an optically active imine represented by the general formula [IV] (Met represents a metal and R represents the same meaning as described above.)
The method for producing a stereoselective β-amino acid derivative according to claim 1, which comprises reacting a metal enolate of an acetic acid ester represented by:
−アミノ酸誘導体を環化することを特徴とする請求項2
記載の立体選択的β−ラクタムの製法。4. A compound represented by the general formula [I]: [Q, R and Z have the same meanings as described above. ] Represented by
-Cyclization of the amino acid derivative.
Process for producing the stereoselective β-lactam described.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6785194A JPH07252248A (en) | 1994-03-11 | 1994-03-11 | Beta-lactam-based compound and its sterically selective production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6785194A JPH07252248A (en) | 1994-03-11 | 1994-03-11 | Beta-lactam-based compound and its sterically selective production |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH07252248A true JPH07252248A (en) | 1995-10-03 |
Family
ID=13356883
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6785194A Pending JPH07252248A (en) | 1994-03-11 | 1994-03-11 | Beta-lactam-based compound and its sterically selective production |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH07252248A (en) |
-
1994
- 1994-03-11 JP JP6785194A patent/JPH07252248A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2550533A1 (en) | PROCESS FOR THE PRODUCTION OF PENEM DERIVATIVES | |
US4845210A (en) | Azetidinone derivatives and processes for production thereof | |
CA1234099A (en) | Process for the production of penems | |
EP0197432A2 (en) | Enantioselective process for producing 1-beta-methylcarbapenem antibiotic intermediates | |
JPH0558630B2 (en) | ||
JPH07252248A (en) | Beta-lactam-based compound and its sterically selective production | |
KR100886347B1 (en) | Stereoselective Manufacturing Method of 4-BM using Chiral Adjuvant | |
HU209952B (en) | New process for producing optically active oxazolidine and imidazolidine derivatives | |
US4769451A (en) | Synthesis of carbapenems using n-substituted azetidinones | |
US4740595A (en) | Preparation of azetidinones via N-protected oxirancecarboxamide intermediates | |
JP3748933B2 (en) | Process for producing 1-substituted azetidinone derivatives | |
JPH07252274A (en) | Beta-lactam derivative and its production | |
US4709064A (en) | β-N-substituted aminothiol ester and process for preparing the same | |
US5008404A (en) | Preparation of azetidinones via novel protected intermediates | |
JP3388874B2 (en) | Method for producing β-lactam compound | |
US4827006A (en) | Preparation of azetidinones via novel protected intermediates | |
US5089609A (en) | 4-benzoyl azetidinones | |
US4963670A (en) | Preparation of azetidinones via novel protected intermediates | |
US5145957A (en) | Stereoselective synthesis of a chiral cis 3-beta hydrogen (3R) 4-aroyloxy azetidinone | |
JPH0692962A (en) | Beta-lactam derivative and stereoselective production thereof | |
US5134231A (en) | 3(1-hydoxyethyl)azetidinone compounds and their production | |
Oda et al. | Stereospecific synthesis of a 1β-methylcarbapenem intermediate | |
US4973687A (en) | Synthesis of carbapenems using N-substituted azetidinones | |
JPS61141894A (en) | Productuin of beta-lactam | |
JPH047739B2 (en) |